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RMDO-2, Olig-2 and Synaptophysin Expression Is a Frequent Event in Malignant 
Melanoma: Diagnostic Pitfalls in Glial Tumor  
 
1.Taliya Farooq MD1, 2. Esther C Yoon MD1, 3. Anas Mashlah M.D1, 4. Sina Zomorrodian D.O.1 and 5. George KleinmanMD1. 
1. New York Medical College at Westchester Medical Center, Pathology, Valhalla, NY. 
Malignant melanomas (MM) are known to 
express S-100, HMB-45 and Mart-1 and vimentin 
among intermediate filaments. RMDO-2 (non- 
phosphorylated Neurofilament, NF) expression 
by MM has never been reported in literature and 
this phenomenon is not well-known.  
The diagnosis of MM can be challenging because 
melanoma is notorious for mimicking other 
tumors. Immunopositivity in MM for antigens 
associated with other tumors may further obscure 
the diagnosis, particularly when there is no prior 
history of melanoma. The purpose and aim of this 
study is to determine the frequency of positivity 
for antigens associated with primary central 
nervous system tumors; RMDO-2 protein (non-
phosphorylated NF), CD 56, Synaptophysin and 
Olig-2 in MM. 
 
 DESIGN: 
BACKGROUND: 
USCAP 2017; POSTER NUMBER 
Twenty-four cases MM (N= 24)  including Brain 
(N=14), MM other sites (N=10) were retrieved 
from  LIS of Westchester Medical Center, 
Valhalla, NY;  included 19 cases from males and  
5  cases from females.  
Prior diagnoses were confirmed by re-review of 
hematoxylin and eosin sections and relevant  IHC 
studies (e.g., S100 protein, HMB45 and Melan- 
A).  In addition, representative sections  from 
each case were subjected for IHC stain for CD56 
(Cell Marque, 1:100 dilution), RMDO-2 (Sigma, 
1:100 dilution), Synaptophysin (Ventana, 1:100 
dilution) and Olig-2 (Cell Marque, 1:100 dilution). 
 
 
1) All cases were positive for S100 and at least one of 
the melanocytic markers (e.g. HMB-45 or Melan- A). 
IHC results for other antigens are shown in table below: 
 
RESULTS:  
CONCLUSIONS: 
1) Heterogeneous expression of RMDO-2, Olig-2 and 
synaptophysin was found in significant subsets of MM 
in brain, representing potentially serious diagnostic 
pitfalls. 
2) MM showing anomalous RMDO-2 and synaptophysin 
expression may easily be mistaken for primary CNS 
gliomas and neuroendocrine tumors. Awareness of 
this phenomenon and an appropriate melanocytic iHC 
panel should facilitate the diagnosis of metastatic 
melanoma with unusual immunophenotypes. 
 IMMUNOHISTOCHEMICAL 
STAINS  
MM to Brain MM to Other Sites Total Cases 
S100 protein 13/14 (93%) 7/10 (70%) (20/24) 83% 
RMDO-2 13/14 (93%) 1/10 (10%) (14/24) 58% 
Olig-2 1/14 (7%) 4/10 (40%) (5/24) 21% 
Synaptophysin 3/14 (21%) 4/10 (40%) (7/24) 29% 
CD-56 2/14 (14%) 5/10 (50%) (7/24) 29% 
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